Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement

International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 4, 2017 Mar 15 | Ferris, Matthew J., MD; Danish, Hasan, MD; Switchenko, Jeffrey M., PhD;...
Summary Dose escalation to gross residual disease in high-risk neuroblastoma is now common. The benefit remains unclear, and the limited evidence suggests increased toxicity at doses above 30 Gy. Here we offer a series of 67 patients treated with ...

http://ift.tt/2lDzNYu

http://ift.tt/2mtAa78